Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Clinical trial NCT01463059 · COMPLETED
Trial details
- NCT number
- NCT01463059
- Sponsor
- UCB Japan Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.